Zhenyu Yue, Ph. D.

Published Contributions:
29 Jul 2009 06:44 PM EST
Although LRRK2 is considered one of the most promising drug targets for PD, currently we know very little about its biological function and structure, or how LRRK2 mutations affect its functions that ... 
4 Feb 2010 11:25 AM EST
Dr. Zhenyu Yue of Mount Sinai School of Medicine discusses two new BAC Lrrk2 mouse models, recently published in Journal of Neuroscience.  As The Michael J. Fox Foundation partially funded this ... 
LRRK2 Antibodies
3 Jun 2010 04:44 PM EST
Brain treatment and Immunohistochemistry: FLAG-LRRK2-WT transgenic mouse and littermate non-transgenic control mouse were anesthetized and perfused with 30ml cold PBS (pH 7.4) and 30ml 4% ...